TG Therapeutics Inc (TGTX)
24.61
-2.29
(-8.51%)
USD |
NASDAQ |
Nov 04, 13:10
TG Therapeutics Revenue (Quarterly): 73.47M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 73.47M |
| March 31, 2024 | 63.47M |
| December 31, 2023 | 43.97M |
| September 30, 2023 | 165.82M |
| June 30, 2023 | 16.07M |
| March 31, 2023 | 7.803M |
| December 31, 2022 | 0.08M |
| September 30, 2022 | 0.094M |
| June 30, 2022 | 0.594M |
| March 31, 2022 | 2.016M |
| December 31, 2021 | 2.321M |
| September 30, 2021 | 2.03M |
| June 30, 2021 | 1.545M |
| March 31, 2021 | 0.793M |
| December 31, 2020 | 0.038M |
| September 30, 2020 | 0.038M |
| June 30, 2020 | 0.038M |
| March 31, 2020 | 0.038M |
| December 31, 2019 | 0.038M |
| September 30, 2019 | 0.038M |
| June 30, 2019 | 0.038M |
| March 31, 2019 | 0.038M |
| December 31, 2018 | 0.038M |
| September 30, 2018 | 0.038M |
| June 30, 2018 | 0.038M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.038M |
| December 31, 2017 | 0.038M |
| September 30, 2017 | 0.038M |
| June 30, 2017 | 0.038M |
| March 31, 2017 | 0.038M |
| December 31, 2016 | 0.0377M |
| September 30, 2016 | 0.0381M |
| June 30, 2016 | 0.0381M |
| March 31, 2016 | 0.0381M |
| December 31, 2015 | 0.0381M |
| September 30, 2015 | 0.0381M |
| June 30, 2015 | 0.0381M |
| March 31, 2015 | 0.0381M |
| December 31, 2014 | 0.0381M |
| September 30, 2014 | 0.0381M |
| June 30, 2014 | 0.0381M |
| March 31, 2014 | 0.0381M |
| December 31, 2013 | 0.0381M |
| September 30, 2013 | 0.0381M |
| June 30, 2013 | 0.0381M |
| March 31, 2013 | 0.0381M |
| December 31, 2012 | 0.019M |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.038M
Minimum
Dec 2019
165.82M
Maximum
Sep 2023
20.01M
Average
1.545M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
| ADMA Biologics Inc | 107.19M |
| Varex Imaging Corp | 209.10M |
| Rhythm Pharmaceuticals Inc | 29.08M |
| AdaptHealth Corp | 595.03M |
| Inspire Medical Systems Inc | 195.88M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 6.879M |
| Total Expenses (Quarterly) | 64.65M |
| EPS Diluted (Quarterly) | 0.04 |
| Enterprise Value | 4.050B |
| Gross Profit Margin (Quarterly) | 88.70% |
| Profit Margin (Quarterly) | 9.36% |
| Earnings Yield | 2.44% |
| Operating Earnings Yield | 2.68% |
| Normalized Earnings Yield | 2.438 |